Personal information

Other IDs

Scopus Author ID: 36009729300

Keywords

Diabetes, Cardiology, Genetics, Epidemiology

Countries

Denmark

Activities

Collapse all

Works (50 of 156)

Items per page:
Page 1 of 4

Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trial

Nature Medicine
2024-01 | Journal article
DOI: 10.1038/s41591-023-02679-9
Contributors: Anders G. Holst; János Tomcsányi; Birgitte Vestbjerg; Morten Grunnet; Ulrik S. Sørensen; Jonas G. Diness; Bo H. Bentzen; Nils Edvardsson; Stefan H. Hohnloser; Deepak L. Bhatt et al.
Source: check_circle
Crossref

Chloroquine, but not hydroxychlorquine, prolongs the QT interval in a primary care population

2020-06-20 | Other
DOI: 10.1101/2020.06.19.20135475
Contributors: Jonas L. Isaksen; Anders G. Holst; Adrian Pietersen; Jonas B. Nielsen; Claus Graff; Jørgen K. Kanters
Source: check_circle
Crossref

Long-Term Prognostic Value of Less-Stringent Electrocardiographic Q Waves and Fourth Universal Definition of Myocardial Infarction Q Waves

The American Journal of Medicine
2020-05 | Journal article
DOI: 10.1016/j.amjmed.2019.08.056
Contributors: Christoffer Polcwiartek; Kristian Kragholm; Daniel J. Friedman; Brett D. Atwater; Claus Graff; Jonas B. Nielsen; Anders G. Holst; Johannes J. Struijk; Adrian Pietersen; Jesper H. Svendsen et al.
Source: check_circle
Crossref

Der Einfluss gastrointestinaler unerwünschter Ereignisse auf die Gewichtsabnahme unter Semaglutid bei Menschen mit Typ 2 Diabetes

Diabetologie und Stoffwechsel
2018 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

Die Abnahme der Insulinresistenz bei Patienten mit Typ 2 Diabetes durch Semaglutid ist primär durch die Gewichtsabnahme vermittelt (SUSTAIN 1--3)

Diabetologie und Stoffwechsel
2018 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

Effect of once-weekly semaglutide on the counterregulatory response to hypoglycaemia in subjects with type 2 diabetes: a randomised, placebo-controlled, double-blind, crossover trial

Diabetes, Obesity and Metabolism
2018 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

Efficacy and safety of once-Weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): A 56-Week, open-Label, randomized clinical trial

Diabetes Care
2018 | Journal article
DOI: 10.2337/dc17-0417
EID:

2-s2.0-85041220578
Contributors: Ahmann, A.J.; Capehorn, M.; Charpentier, G.; Dotta, F.; Henkel, E.; Lingvay, I.; Holst, A.G.; Annett, M.P.; Aroda, V.R.
Source: Self-asserted source
Anders Gaarsdal Holst via Scopus - Elsevier

Genome-wide association study of 1 million people identifies 111 loci for atrial fibrillation

bioRxiv
2018 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

Heart transplantation in arrhythmogenic right ventricular cardiomyopathy — Experience from the Nordic ARVC Registry

International Journal of Cardiology
2018 | Journal article
DOI: 10.1016/j.ijcard.2017.10.076
EID:

2-s2.0-85032343360
Contributors: Gilljam, T.; Haugaa, K.H.; Jensen, H.K.; Svensson, A.; Bundgaard, H.; Hansen, J.; Dellgren, G.; Gustafsson, F.; Eiskjær, H.; Andreassen, A.K. et al.
Source: Self-asserted source
Anders Gaarsdal Holst via Scopus - Elsevier

Heart transplantation in arrhythmogenic right ventricular cardiomyopathy—Experience from the Nordic ARVC Registry

International journal of cardiology
2018 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

Risk prediction of atrial fibrillation based on electrocardiographic interatrial block

Journal of the American Heart Association
2018 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

Risk prediction of atrial fibrillation based on electrocardiographic interatrial block

Journal of the American Heart Association
2018 | Journal article
DOI: 10.1161/JAHA.117.008247
EID:

2-s2.0-85047999051
Contributors: Skov, M.W.; Ghouse, J.; Kühl, J.T.; Platonov, P.G.; Graff, C.; Fuchs, A.; Rasmussen, P.V.; Pietersen, A.; Nordestgaard, B.G.; Torp-Pedersen, C. et al.
Source: Self-asserted source
Anders Gaarsdal Holst via Scopus - Elsevier

Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in SUSTAIN 1--5 trials

Diabetes, Obesity and Metabolism
2018 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

SUSTAIN 6: Effekt von Semaglutid auf kardiovaskuläre Endpunkte im zeitlichen Verlauf bei Patienten mit Typ 2 Diabetes (Post-hoc Auswertung)

Diabetologie und Stoffwechsel
2018 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

Effect of once-weekly semaglutide on the counterregulatory response to hypoglycaemia in people with type 2 diabetes: A randomized, placebo-controlled, double-blind, crossover trial

Diabetes, Obesity and Metabolism
2018-07 | Journal article
DOI: 10.1111/dom.13422
Part of ISSN: 1462-8902
Contributors: Stefan Korsatko; Lene Jensen; Martina Brunner; Stefanie Sach-Friedl; Maja D. Tarp; Anders G. Holst; Simon R. Heller; Thomas R. Pieber
Source: Self-asserted source
Anders Gaarsdal Holst via Crossref Metadata Search

Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials

Diabetes, Obesity and Metabolism
2018-06 | Journal article
DOI: 10.1111/dom.13353
Part of ISSN: 1462-8902
Contributors: Bo Ahrén; Stephen L. Atkin; Guillaume Charpentier; Mark L. Warren; John P. H. Wilding; Sune Birch; Anders Gaarsdal Holst; Lawrence A. Leiter
Source: Self-asserted source
Anders Gaarsdal Holst via Crossref Metadata Search

3877Primary prevention of sudden death with ICD therapy in the Nordic arrhythmogenic cardiomyopathy registry

European Heart Journal
2017 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

99Predictors of ventricular arrhythmias in the Nordic arrhythmogenic right ventricular cardiomyopathy registry: first experience from the prospective multicenter Scandinavian cohort

European Heart Journal
2017 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

99Predictors of ventricular arrhythmias in the Nordic arrhythmogenic right ventricular cardiomyopathy registry: first experience from the prospective multicenter Scandinavian cohort

European Heart Journal
2017 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

Association of traditional cardiovascular risk factors with venous thromboembolism

Circulation
2017 | Journal article
DOI: 10.1161/CIRCULATIONAHA.116.024507
EID:

2-s2.0-84996866012
Contributors: Mahmoodi, B.K.; Cushman, M.; Næss, I.A.; Allison, M.A.; Bos, W.J.; Brækkan, S.K.; Cannegieter, S.C.; Gansevoort, R.T.; Gona, P.N.; Hammerstrøm, J. et al.
Source: Self-asserted source
Anders Gaarsdal Holst via Scopus - Elsevier

Association of Traditional Cardiovascular Risk Factors With Venous ThromboembolismClinical Perspective: An Individual Participant Data Meta-Analysis of Prospective Studies

Circulation
2017 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

Atrial fibrillation detected by continuous electrocardiographic monitoring using implantable loop recorder to prevent stroke in individuals at risk (the LOOP study): Rationale and design of a large randomized controlled trial

American heart journal
2017 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

Complications after implantation of a new-generation insertable cardiac monitor: Results from the LOOP study

International journal of cardiology
2017 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

Effect of semaglutide on the pharmacokinetics of metformin, warfarin, atorvastatin and digoxin in healthy subjects

Clinical pharmacokinetics
2017 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

Effect of Semaglutide on the Pharmacokinetics of Metformin, Warfarin, Atorvastatin and Digoxin in Healthy Subjects

Clinical Pharmacokinetics
2017 | Journal article
DOI: 10.1007/s40262-017-0532-6
EID:

2-s2.0-85016100455
Contributors: Hausner, H.; Derving Karsbøl, J.; Holst, A.G.; Jacobsen, J.B.; Wagner, F.-D.; Golor, G.; Anderson, T.W.
Source: Self-asserted source
Anders Gaarsdal Holst via Scopus - Elsevier

Effet du semaglutide sur la réponse de contre-régulation hormonale à l’hypoglycémie chez les diabétiques de type 2

Diabetes & Metabolism
2017 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): a 56-week, open-label, randomized clinical trial

Diabetes care
2017 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

Electrocardiographic PR interval duration and cardiovascular risk: results from the Copenhagen ECG study

Canadian Journal of Cardiology
2017 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

Electrocardiographic Preexcitation and Risk of Cardiovascular Morbidity and Mortality

Circulation
2017 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

Electrocardiographic Preexcitation and Risk of Cardiovascular Morbidity and Mortality: Results from the Copenhagen ECG Study

Circulation: Arrhythmia and Electrophysiology
2017 | Journal article
DOI: 10.1161/CIRCEP.116.004778
EID:

2-s2.0-85021065225
Contributors: Skov, M.W.; Rasmussen, P.V.; Ghouse, J.; Hansen, S.M.; Graff, C.; Olesen, M.S.; Pietersen, A.; Torp-Pedersen, C.; Haunsø, S.; Køber, L. et al.
Source: Self-asserted source
Anders Gaarsdal Holst via Scopus - Elsevier

Electrocardiographic Preexcitation and Risk of Cardiovascular Morbidity and Mortality: Results From the Copenhagen ECG Study

Circulation: Arrhythmia and Electrophysiology
2017 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

Le semaglutide améliore la glycémie post-prandiale, le métabolisme lipidique et retarde la vidange gastrique de la 1re heure chez les obèses

Diabetes & Metabolism
2017 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

Le semaglutide améliore la glycémie post-prandiale, le métabolisme lipidique et retarde la vidange gastrique de la 1re heure chez les obèses

Diabetes & Metabolism
2017 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

The New England journal of medicine
2017 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

Semaglutide-induced reductions in insulin resistance are mediated primarily via weight loss in subjects with type 2 diabetes (SUSTAIN 1-3)

Diabetologia
2017 | Conference paper
Source: Self-asserted source
Anders Gaarsdal Holst

SUSTAIN 6: A POST-HOC ANALYSIS OF THE EFFECT OF SEMAGLUTIDE ON CARDIOVASCULAR OUTCOMES OVER TIME IN SUBJECTS WITH TYPE 2 DIABETES

Canadian Journal of Cardiology
2017 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

SUSTAIN 6: analyse post-hoc de la survenue des événements cardiovasculaires majeurs au cours des 2 ans de suivi

Annales d'Endocrinologie
2017 | Conference paper
Source: Self-asserted source
Anders Gaarsdal Holst

SUSTAIN 6: une analyse post-hoc sur la dynamique de survenue d’événements cardio-vasculaires majeurs au cours des 2 ans de la période d’étude

2017 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

The authors reply

New England Journal of Medicine
2017 | Journal article
DOI: 10.1056/NEJMc1615712
EID:

2-s2.0-85014786451
Contributors: Marso, S.P.; Holst, A.G.; Vilsbøll, T.
Source: Self-asserted source
Anders Gaarsdal Holst via Scopus - Elsevier

The impact of gastrointestinal adverse events on weight loss with semaglutide in subjects with type 2 diabetes

DIABETOLOGIA
2017 | Conference paper
Source: Self-asserted source
Anders Gaarsdal Holst

Étude SUSTAIN 3: efficacité et tolérance du semaglutide une fois par semaine versus exanatide-LP après 56 semaines chez des diabétiques de type 2

Diabetes & Metabolism
2017 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst

Complications after implantation of a new-generation insertable cardiac monitor: Results from the LOOP study

International Journal of Cardiology
2017-08 | Journal article
DOI: 10.1016/j.ijcard.2017.03.144
Part of ISSN: 0167-5273
Contributors: Søren Zöga Diederichsen; Ketil Jørgen Haugan; Søren Højberg; Anders Gaarsdal Holst; Lars Køber; Kenneth Bruun Pedersen; Claus Graff; Derk Krieger; Axel Brandes; Jesper Hastrup Svendsen
Source: Self-asserted source
Anders Gaarsdal Holst via Crossref Metadata Search

Atrial fibrillation detected by continuous electrocardiographic monitoring using implantable loop recorder to prevent stroke in individuals at risk (the LOOP study): Rationale and design of a large randomized controlled trial

American Heart Journal
2017-05 | Journal article
DOI: 10.1016/j.ahj.2017.02.017
Part of ISSN: 0002-8703
Contributors: Søren Zöga Diederichsen; Ketil Jørgen Haugan; Lars Køber; Søren Højberg; Axel Brandes; Christian Kronborg; Claus Graff; Anders Gaarsdal Holst; Jonas Bille Nielsen; Derk Krieger et al.
Source: Self-asserted source
Anders Gaarsdal Holst via Crossref Metadata Search

Electrocardiographic PR Interval Duration and Cardiovascular Risk: Results From the Copenhagen ECG Study

Canadian Journal of Cardiology
2017-05 | Journal article
DOI: 10.1016/j.cjca.2017.02.015
Part of ISSN: 0828-282X
Contributors: Peter Vibe Rasmussen; Jonas Bille Nielsen; Morten Wagner Skov; Adrian Pietersen; Claus Graff; Bent Lind; Johannes Jan Struijk; Morten Salling Olesen; Stig Haunsø; Lars Køber et al.
Source: Self-asserted source
Anders Gaarsdal Holst via Crossref Metadata Search

Étude SUSTAIN 3 : efficacité et tolérance du semaglutide une fois par semaine versus exanatide-LP après 56 semaines chez des diabétiques de type 2

Diabetes & Metabolism
2017-03 | Journal article
DOI: 10.1016/s1262-3636(17)30421-4
Part of ISSN: 1262-3636
Contributors: Guillaume Charpentier; Amira Bouzidi; Andrew Ahmann; Matthew Capehorn; Francesco Dotta; Elena Henkel; Ildiko Lingvay; Anders Gaarsdal Holst; Miriam Annett; Vanita R. Aroda
Source: Self-asserted source
Anders Gaarsdal Holst via Crossref Metadata Search

A vectorcardiographic evaluation of the consensus criteria for early repolarization

Computing in Cardiology, CinC
2016 | Conference paper
Source: Self-asserted source
Anders Gaarsdal Holst

A vectorcardiographic evaluation of the consensus criteria for early repolarization

Computing in Cardiology
2016 | Conference paper
EID:

2-s2.0-85016119562
Contributors: Sorensen, P.L.; Sorensen, K.; Melgaard, J.; Struijk, J.J.; Hansen, S.M.; Kanters, J.K.; Nielsen, J.B.; Svendsen, J.H.; Haunsoe, S.; Koeber, L. et al.
Source: Self-asserted source
Anders Gaarsdal Holst via Scopus - Elsevier

Association Between Heart Rate at Rest and Incident Atrial Fibrillation (from the Copenhagen Electrocardiographic Study)

American Journal of Cardiology
2016 | Journal article
DOI: 10.1016/j.amjcard.2016.06.013
EID:

2-s2.0-84979669608
Contributors: Skov, M.W.; Bachmann, T.N.; Rasmussen, P.V.; Olesen, M.S.; Pietersen, A.; Graff, C.; Lind, B.; Struijk, J.J.; Køber, L.; Haunsø, S. et al.
Source: Self-asserted source
Anders Gaarsdal Holst via Scopus - Elsevier

Effect of once-weekly semaglutide on the counter-regulatory response to hypoglycaemia in subjects with type 2 diabetes

DIABETOLOGIA
2016 | Conference paper
Source: Self-asserted source
Anders Gaarsdal Holst

Effect of once-weekly subcutaneous treatment with semaglutide, a GLP-1 analog, on metformin, warfarin, atorvastatin and digoxin in healthy subjects

ENDO
2016 | Journal article
Source: Self-asserted source
Anders Gaarsdal Holst
Items per page:
Page 1 of 4
How many people are using ORCID?